Positive results from Phase 3 CONFIRM clinical trial show efficacy and safety of oral BG-12 in multiple sclerosis Biogen Idec, 24 Apr 2012 Accessed on 16 May 2012 from http://www.biogenidec.com/PRESS_RELEASE_DETAILS.aspx?ID=5981&ReqId=1686377. CommentRecommendBookmarkWatch
